SCHEMBL25978446

SCHEMBL25978446

c1ccc(-c2ccc(N(c3ccccc3)c3cccc4oc5cc(-c6cc(-c7ccc8ccccc8c7)nc(-c7ccccc7)n6)ccc5c34)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.39
CYP1B1 Q16678 1/20 0.39
MEN1 O00255 6/20 0.36
KMT2A Q03164 6/20 0.36
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 3/20 0.36
CYP1A2 P05177 3/20 0.36
TP53 P04637 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
HPGD P15428 4/20 0.35
MAPT P10636 3/20 0.35
LMNA P02545 2/20 0.35
GLA P06280 1/20 0.35
NTSR1 P30989 1/20 0.33
MAOB P27338 3/20 0.32
MAOA P21397 2/20 0.32
CTRC Q99895 1/20 0.32
RAC1 P63000 2/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26778943 0.98 CYP1A1 (0.41) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL26778908 0.95 CYP1A2 (0.38) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25978388 0.95 CYP1A2 (0.38) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25978512 0.94 CYP1A2 (0.37) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL26778914 0.94 CYP1A2 (0.36) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25978447 0.94 MEN1 (0.40) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25978421 0.94 MEN1 (0.40) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25978420 0.94 MEN1 (0.40) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25978422 0.94 MEN1 (0.40) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL26778940 0.91 MEN1 (0.39) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 CYP1A1 2/4885CYP1B1 3/4885MEN1 257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.